Concepedia

S. Wilk

SW

Statistics

Publications

30

Citations

3.2K

H-Index

23

Active since

1966

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

City University of New York

Mount Sinai Hospital

University of Freiburg

Universidad Nacional Autónoma de México

S. Wilk is an author at Icahn School of Medicine at Mount Sinai specializing in life sciences, biochemistry, and molecular biology.

Publications per year

1966–1999

30

Publications

30

Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli.

E. Britta-Mareen Traenckner, Heike L. Pahl, Timothy P. Henkel et al. · The EMBO Journal · 1995 · 1K citations · Full text

, , +11

A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B.

E. Britta-Mareen Traenckner, S. Wilk, Patrick A. Baeuerle · The EMBO Journal · 1994 · 717 citations · Full text

, , +10

Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.

J M Griscavage, S. Wilk, Louis J. Ignarro · Proceedings of the National Academy of Sciences · 1996 · 268 citations

, , +14

Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome.

Cezary Wójcik, D. Schroeter, S. Wilk et al. · PubMed · 1996 · 144 citations

, , +11

gamma-Glutamyl dopa: a kidney-specific dopamine precursor.

S. Wilk, Haruko Mizoguchi · Journal of Pharmacology and Experimental Therapeutics · 1978 · 119 citations

, , +16

1–5 of 30